access to glp 1 CMS Expands GLP-1 Medications for Medicare Beneficiaries A New Approach for the
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 218
Eur J Epidemiol 34(3):223224
This study is based on data from the CPRD obtained under licence from the UK Medicines and Healthcare products Regulatory Agency
Filed over trademark misuse and unapproved drug imports, the case saw an Administrative Law Judge recommend a general exclusion order in December 2024 banning all infringing tirzepatide imports
